AVITA Medical (RCEL) Change in Accured Expenses (2019 - 2025)
AVITA Medical (RCEL) posted Change in Accured Expenses of $1.0 million for Q4 2025, up 28.78% on a QoQ basis from $806000.0 in Q3 2025, and up 182.25% year-over-year from $367758.6 in Q4 2024.
AVITA Medical (RCEL) Change in Accured Expenses (2019 - 2025) Analysis & Trends
AVITA Medical's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- Quarterly Change in Accured Expenses rose 182.25% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 306.86% YoY) and the FY2025 annual result came in at $2.7 million, up 306.86% from the prior year.
- Change in Accured Expenses was $1.0 million for Q4 2025 at AVITA Medical, up from $806000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.0 million in Q2 2025 and bottomed at -$2.4 million in Q1 2022.
- A 5-year average of $127470.6 and a median of $16000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses jumped 1500.0% — and 2022, when it slumped 17400.0%.
- AVITA Medical's Change in Accured Expenses stood at $70000.0 in 2021, then surged by 3918.57% to $2.8 million in 2022, then plunged by 102.81% to -$79000.0 in 2023, then slumped by 1497.47% to -$1.3 million in 2024, then surged by 182.25% to $1.0 million in 2025.
- Business Quant data shows RCEL's Change in Accured Expenses at $1.0 million in Q4 2025, $806000.0 in Q3 2025, and $3.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | AVITA Medical | 133.04 Mn | 116.69 Mn | 14.31 Mn | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 806,000.00 |
| Sep 30, 2025 | 806,000.00 |
| Jun 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 283,000.00 |
| Sep 30, 2024 | 283,000.00 |
| Jun 30, 2024 | -239,000.00 |
| Jun 30, 2024 | -239,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Sep 30, 2023 | 566,000.00 |
| Sep 30, 2023 | 566,000.00 |